Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTA: Pharmacist-Led Vascular Risk Factor Management in APOE ε4 Carriers
NCT07447206Phase 2Not yet recruiting
- Sponsor
- University of Southern California
- Start
- May 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in hypertension (HTN) and hypercholesterolemia, sponsored by University of Southern California. Primary endpoint: Blood Pressure Control at 6 months. Planned start May 2026; status: not yet recruiting.
02
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT07447206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07447206.